CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
How Much Energy Do You Throw Away Aft er Lights Out?
Editorial Archive

How Much Energy Do You Throw Away Aft er Lights Out?

When the last person out at night turns off the lights, how many of us are lulled into a false sense of security into thinking that the energy consumption of o...
Continue Reading →
The Big Data Cure-all?
Editorial Archive

The Big Data Cure-all?

Data management is an issue for any business these days, but particularly in life sciences where growing regulatory demands and commercial pressures are increa...
Continue Reading →
Comparison of Marketing Authorisation and its Requirements for Singapore and Thailand
Editorial Archive

Comparison of Marketing Authorisation and its Requirements for Singapore and Thailand

The availability of generic medication is an important issue in the ASEAN regions. The regulatory requirements of various countries of the world vary from each...
Continue Reading →
Denmark; Small and Personalised
Editorial Archive

Denmark; Small and Personalised

Personalised medicine means giving the right medicine in the right dosage to the right group of patients at the right time. Research involves developing method...
Continue Reading →
Feasibility is not (anymore) A Plain Search for Investigational Sites
Editorial Archive

Feasibility is not (anymore) A Plain Search for Investigational Sites

Conceptual Evolution of Feasibility Studies in Pharmaceutical Development The sole term ‘feasibility’ has multiple definitions in a clinical environment, leading...
Continue Reading →
Natural Born Killers
Editorial Archive

Natural Born Killers

Immunotherapy is currently one of the most actively pursued areas of research by biotechnology and pharmaceutical companies. “Control of immune activation can sa...
Continue Reading →
The Devil in the Detail: Five Routine Recall Risks Faced by Modern Pharma
Editorial Archive

The Devil in the Detail: Five Routine Recall Risks Faced by Modern Pharma

With the steely eyes of the regulators firmly trained on everything that life sciences organisations do, the last thing firms want is to incur fines, market dela...
Continue Reading →
Tipping Point: The Regulatory Year in Review
Editorial Archive

Tipping Point: The Regulatory Year in Review

As big an issue as it has become, compliance is the least of life sciences companies’ concerns as 2016 gives way to 2017. But the right approach will equip compa...
Continue Reading →
Regulatory Transformation: Cloud Reality Check
Editorial Archive

Regulatory Transformation: Cloud Reality Check

What role can cloud services such as SaaS play in driving the next generation of regulatory information management, and what are the practical considerations for...
Continue Reading →
The Global Impact of Standards
Editorial Archive

The Global Impact of Standards

rise of legislation and government initiatives to make the use of medicines and medical equipment as safe and cost-effective as possible. With an ageing populati...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026